Key result
Pre-dialysis SBP ≥150 mmHg is linked to ~22% higher risk of MACCE or death.
Why the study?
Is higher pre-dialysis systolic blood pressure associated with an increased risk of major adverse cardiac and cerebrovascular events or all-cause death in patients receiving hemodialysis?
Cohort (n=39,974)
Yes
Is higher pre-dialysis systolic blood pressure associated with an increased risk of major adverse cardiac and cerebrovascular events or all-cause death in patients receiving hemodialysis?
Pre-dialysis systolic blood pressure is linearly associated with MACCE and death in hemodialysis patients, with a more pronounced association at higher intradialytic weight loss.
Answers are grounded in this paper and cite their sources.
Optimal pre-dialysis SBP targets in hemodialysis remain uncertain; this cohort analysis leaves open the ideal range for cardiovascular risk reduction.
Background Despite the high risk of cardiovascular disease in patients with end-stage kidney disease, the optimal blood pressure (BP) remains unclear. We aimed to explore the association between pre-dialysis systolic BP (SBP) and cardiovascular outcomes. Methods Data from patients in the Korean National Periodic Hemodialysis Quality Assessment Program were used. Participants were categorized into five groups according to mean pre-dialysis SBP during the assessment period. The primary outcome was major adverse cardiac and cerebrovascular events (MACCE), a composite of non-fatal myocardial infarction, coronary revascularization, non-fatal stroke, or hospitalization for heart failure, or all-cause death. Results In total, data from 39,974 patients were included. During 221,634 person-years of follow-up (median of 5.6 years), MACCE occurred in 25,135 patients (62.9%). In the multivariable Cox proportional hazards model, hazard ratios (95% confidence intervals) for MACCE were 0.93 (0.87-1.00), 1.06 (1.01-1.11), 1.12 (1.06-1.17), and 1.22 (1.17-1.28) for the <120, 130-139, 140-149, and ≥150 mmHg groups, respectively, compared with the 120-129 mmHg group. Each SBP 10 mmHg-increase was associated with a 1.06-fold higher risk of MACCE. In an exploratory analysis, the association between pre-dialysis SBP and MACCE differed across quartiles of intradialytic weight loss (IDWL, %), being more pronounced at higher IDWL. Conclusions Pre-dialysis SBP was linearly associated with the risk of MACCE after adjusting for individual IDWL. In the exploratory analysis, the magnitude of this association differed according to IDWL, suggesting that pre-dialysis SBP may need to be interpreted together with the fluid removed at each session.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) conducted a cohort in End-stage kidney disease receiving hemodialysis (n=39,974). Mean pre-dialysis systolic blood pressure (<120, 130-139, 140-149, and ≥150 mmHg) vs. Pre-dialysis systolic blood pressure 120-129 mmHg was evaluated on Major adverse cardiac and cerebrovascular events (MACCE), a composite of non-fatal myocardial infarction, coronary revascularization, non-fatal stroke, hospitalization for heart failure, or all-cause death (HR 1.22, 95% CI 1.17-1.28). Pre-dialysis SBP ≥150 mmHg vs 120-129 mmHg was associated with higher risk of MACCE or all-cause death, with a 1.06-fold higher risk per 10 mmHg increase.
Synapse has enriched 10 related papers. Consider them for comparative context: